packageTasonermin

tasonermin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tasonermin is an immunostimulant anticancer medicine used to treat sarcoma. It is authorised in the European Union and is restricted to hospital use, where it is given by isolated limb perfusion for sarcoma in a limb.

Summary written by glm-5.3-flash from Wikidata Q28852342 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tasonermin
ATC codes:L03AX11
DrugBank:DB11626
Wikidata:Q28852342
molar mass:17724 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown